(HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting ...

The Florida sun is brutal, and while slathering on sunscreen feels like a no-brainer, this summer the rules have changed.

The doctor asks, "What is this? Some kind of sick joke?" It takes guts to be an organ donor. I’ve got this awful disease ...

A revolutionary scanning technique has revealed that lithium MRI is a powerful tool for studying how the drug interacts with ...

New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among ...

Belgium's AZ Maria Middelares is proud to take on a pioneering role as a technology-driven health care organization.

In a shareholder letter dated January 27, 2026, INmune Bio reviewed 2025 as a pivotal year marked by progress in two lead programs and solidified financial footing. The company reported substantial ...